NV-1NCE
1NCE, a global IoT connectivity and software company, today announced the creation of its software business unit in conjunction with the Consumer Electronics Show launch of 1NCE OS – IoT software offering powerful developer tools and device control to make IoT even more accessible.
The software tools are an integral part of 1NCE’s Lifetime Flat service and are available complimentary to 1NCE customers.
1NCE OS is a foundational element of the company’s ambitious goal: to cement 1NCE’s standing as the preeminent destination for accessible IoT. It’s designed for easy integration of 1NCE’s connectivity and software features into IoT projects of any scale, for new and existing projects alike. Using 1NCE OS for device and cloud integration, customers can accelerate time-to-market for IoT projects by months. One of 1NCE’s core principles is that customer data isn’t to be monetized and used to sell additional services. Instead, 1NCE is transparent about turning data into tools that are included in the global lifetime flat rate.
Features available at launch:
- Device Authentication: The process of setting up a secure and automated solution usually requires a complicated and error-prone onboarding process. 1NCE OS makes it simple: customers just solder the secure SIM into their device just like any other hardware piece and that’s it – delivering better authentication and integration of uniquely identified devices into IoT projects.
- IoT Integrator: Reliably connecting devices to the cloud can be complex, but 1NCE’s managed protocol translation uses open industry standards (UDP, CoAP, LwM2M, AWS IoT Core, Webhooks) to give customers the free and full flexibility they demand.
- Device Inspector: The time-intensive and costly process of sending technicians into the field to monitor and service devices is significantly reduced using advanced remote access to device states and recent telemetry.
- Device Locator: Network based positioning helps users locate devices even without GPS.
- Energy Saver: The inherent challenges of battery-powered devices make power usage a high priority, and 1NCE’s optimized payload transmission can increase battery life by up to 50 percent.
Fredrik Stålbrand of Berg Insights said: “1NCE OS and 1NCE’s product roadmap look very compelling. Our view is that the IoT connectivity market will increasingly move towards digitalized sales and delivery. SIMs will be pre-installed in chipsets, while connectivity management is increasingly being controlled by SaaS applications. Customers expect simple, digital experiences throughout the product lifecycle. 1NCE is clearly at the forefront of this development.”
Ivo Rook, Chief Operating Officer at 1NCE: “1NCE flips the script for customers – we don’t monetize their data for a few extra dollars because our customers’ data is theirs and theirs alone. 1NCE’s move into software allows us to boost our customers’ ideas not just when they need connectivity, but from the outset of their projects and all the way through a device’s lifecycle. IoT connectivity and software for life for a single fee, and that’s it.”
Fifty percent of failed IoT projects falter in the pilot stage. For new IoT projects, 1NCE makes it easy to experiment early without major expenditures that can kill a project. Customers connect sensors across the globe at a fraction of the cost of the traditional price of network operators, and now with 1NCE OS, they gain access to software tools that accelerate time-to-market without vendor lock-in or paying for unnecessary features packaged into most IoT platforms. And for IoT projects that are already up and running, 1NCE’s combination of connectivity and software delivers trusted, production-grade solutions for continuous improvement and optimization.
The majority of IoT projects require multinational deployments, but few network operators have the capability to truly meet cross-border demands. The 1NCE Lifetime Flat service is industry-disruptive but simple: for $10/€10, customers can deploy, connect, and manage IoT sensors across the world for as little as a dollar per year per device. More than 10,000 customers worldwide already trust 1NCE with more than 15 million managed connections.
The company’s ability to deliver affordable and reliable IoT, and its rapid global expansion to 153 markets from 106 at the beginning of the year, helped 1NCE earn two prestigious awards recently: Honorable Mention on Fast Company’s list of the Next Big Things in Tech and top prize for the most outstanding use case in “innovative IoT” (in partnership with Flashnet) at Light Reading’s 18th annual Leading Lights.
More information about 1NCE OS can be found here and customers can get started with 1NCE at the company’s online shop and the AWS Marketplace. Customer support is available in 14 languages.
About 1NCE
1NCE is the only connectivity and software company providing IoT at a lifetime global flat rate. Our mission is to deliver true cross-border, future-proof IoT without uncertainty or hassle over the lifetime of a device. In 150+ countries, 1NCE turns connectivity into electricity ready for consumption – opening the world of IoT to innovators who will dramatically improve the environment, cities, healthcare, public safety, the supply chain and more. The company, founded in 2017 by CEO Alexander P. Sator together with Deutsche Telekom AG, is headquartered in Cologne, Germany and has 250+ staff across 20 countries. Learn more online and follow 1NCE on Twitter, LinkedIn and Facebook.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230105005461/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom